$28.35
Today
as of Oct 2, 16:49 ET
Last 30 days
Recent Press Releases & News
Faeth Therapeutics Appoints Karen Vousden, Ph.D., to Board of Directors
Guggenheim Initiates Faeth Therapeutics at Buy With $70 Price Target
TD Cowen Initiates Coverage on Faeth Therapeutics With Buy Rating
FTH earnings at a glance
FTH beat the consensus EPS estimate in 2 of its last 2 reported quarters. The share price of $28.35 sits in the middle of its 52-week range.
Overview
52-week range
$7.45
$42
60% of range
Avg surprise (last 2)
+24.4%
Avg reaction (last 0)
—
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-2.84 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-131.45 | — | — | — | — | financials |
| Fri Nov 14, 2025 | Sep/2025 | $-3.62 | $-4.11 | +11.9% | — | — | earnings |
| Tue Aug 5, 2025 | Jun/2025 | $-3.91 | $-6.20 | +36.9% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-5.45 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-5.77 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.69 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.32 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.31 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.33 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-18M | $-171M | — | $-5M | $-5M | $-7M | $-8M | $-8M |
| Net income | $-16M | $-170M | — | $-5M | $-5M | $-7M | $-7M | $-7M |
| EPS (diluted) | $-2.84 | $-131.45 | — | $-3.62 | $-3.91 | $-5.45 | $-5.77 | $-5.69 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27M | $152M | $9M | $11M | $13M | $10M | $19M | $12M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $189M | $204M | $22M | $26M | $30M | $36M | $48M | $54M |
| Total assets | $189M | $205M | $23M | $28M | $32M | $38M | $53M | $60M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $10M | $14M | $4M | $5M | $4M | $6M | $7M | $8M |
| Total equity | $173M | $-137M | $19M | $23M | $27M | $32M | $46M | $52M |
Implied volatility — last 90 days
No IV snapshots yet for FTH.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.